Antiproliferative Effects of Cynara Cardunculus in Colorectal Cancer Cells Are Modulated by the Circadian Clock.
Luise FuhrAlireza BastiTeresa Silva BrásMaria F DuarteAngela RelógioPublished in: International journal of molecular sciences (2022)
The circadian clock generates 24 h rhythms in behavioural, cellular and molecular processes. Malfunctions of the clock are associated with enhanced susceptibility to cancer, worse treatment response and poor prognosis. Clock-controlled genes are involved in cellular processes associated with tumour development and progression including metabolism of drugs and the cell cycle. Cynara cardunculus , a plant of the Asteraceae family, has been reported to have antiproliferative effects on breast cancer cells. Here, we used the human colorectal cancer (CRC) cell line HCT116 and its knockout variants for different core-clock genes ( BMAL1 , PER2 , NR1D1 ), to investigate the treatment effect of C. cardunculus lipophilic leaf extract under different clock scenarios. Our results show a direct effect of C. cardunculus on the circadian phenotype of the cells, as indicated by alterations in the phase, amplitude, and period length of core-clock gene oscillations. Furthermore, our data indicate a role for the circadian clock in sensitivity to C. cardunculus treatment. In particular, the treatment inhibited proliferation and induced cytotoxicity and apoptosis in a clock knockout-specific manner, in CRC cells. These results point to a potential effect of C. cardunculus lipophilic leaf extracts as a modulator of the circadian clock, in addition to its anti-proliferative properties.
Keyphrases
- cell cycle arrest
- cell cycle
- poor prognosis
- induced apoptosis
- genome wide
- cell death
- endothelial cells
- long non coding rna
- endoplasmic reticulum stress
- oxidative stress
- breast cancer cells
- cell proliferation
- risk assessment
- squamous cell carcinoma
- gene expression
- combination therapy
- transcription factor
- genome wide identification
- pi k akt
- papillary thyroid
- replacement therapy
- single molecule
- lymph node metastasis